This public procurement record has 4 releases in its history.

Award

20 Aug 2024 at 10:04

TenderUpdate

08 Jun 2023 at 15:24

TenderUpdate

18 May 2023 at 12:09

Tender

04 May 2023 at 14:09

Summary of the contracting process

The Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5) procurement process, managed by the Peninsula Purchasing and Supply Alliance (PPSA) on behalf of NHS South West - Acutes, targets the supply of pharmaceutical products including cytotoxic and non-cytotoxic medicines. The awarding of the contract covers NHS Trusts within the South West region of England, including Bristol, Devon, Cornwall, Gloucestershire, Somerset, and Wiltshire. The framework, valued at £80,000,000, utilised an open procedure and involved key stakeholders like the Royal Devon University Healthcare NHS Foundation Trust, other South West NHS Trusts, and various suppliers. The procurement is in the award stage, with contracts signed in May and June 2024. Noteworthy deadlines included the time limit for receipt of tenders extended from 16 June 2023 to 13 July 2023.

This tender represents a significant opportunity for businesses specialising in pharmaceutical manufacturing and related services. Notably, companies with capabilities in developing aseptically manipulated or terminally sterile products are well-suited to participate. The framework agreement ensures recurring business and considerable financial inflow, as evidenced by contract values ranging up to £20,000,000 per supplier. Large suppliers like Baxter Healthcare Ltd, Qualasept Ltd t/a Bath ASU, Sciensus Pharma Services Limited, Quantum Pharmaceutical Limited, and Liverpool University Hospitals NHS Foundation Trust have been successfully awarded, indicating a substantial market for quality pharmaceutical services. The emphasis on quality assurance processes suggests that businesses with strong QA practices will have a competitive edge.

How relevant is this notice?

Notice Title

Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5)

Notice Description

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags, pre-filled syringes & elastomeric devices. This procurement is being managed by the PPSA on behalf of the Royal Devon University Healthcare NHS Foundation Trust acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.

Lot Information

Lot 1

Supply of various products in bags, pre-filled syringes to include Arsenic Trioxide, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Blinatumomab, Brentuximab, Bupivacaine, Carfilzomib, Cetuximab, Daratumumab, Eribulin Mesylate, Etoposide, Fludarabine Fluorouracil elastomeric devices, Ifosfamide, Infliximab, Ipilimumab, Methotrexate, Natalizumab, Obinutuzumab, Paclitaxel Albumin, Panitumumab, Pemetrexed, Pertuzumab, Rituximab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Vinorelbine.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-03c658
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/026412-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

33690000 - Various medicinal products

33692100 - Infusion solutions

33692500 - Injectable solutions

33692510 - Intravenous fluids

33693100 - Toxins

Notice Value(s)

Tender Value
£80,000,000 £10M-£100M
Lots Value
£80,000,000 £10M-£100M
Awards Value
Not specified
Contracts Value
£40,000,000 £10M-£100M

Notice Dates

Publication Date
20 Aug 20242 years ago
Submission Deadline
5 Jun 2023Expired
Future Notice Date
Not specified
Award Date
11 Apr 20242 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS South West - Acutes
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EXETER
Postcode
Not specified
Postcode Area
Not specified
Country
Not specified

Major Region (ITL 1)
Not specified
Basic Region (ITL 2)
Not specified
Small Region (ITL 3)
Not specified
Delivery Location
TLK South West (England)

Local Authority
Not specified
Electoral Ward
Not specified
Westminster Constituency
Not specified

Supplier Information

Number of Suppliers
5
Supplier Names

Baxter Healthcare Ltd

Liverpool University Hospitals NHS Foundation Trust

Qualasept Ltd t/a Bath ASU

Quantum Pharmaceutical Limited

Sciensus Pharma Services Limited

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...